Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 21;64(30):e202506785.
doi: 10.1002/anie.202506785. Epub 2025 May 26.

Copper-Photoredox-Catalyzed C(sp3)-C(sp3) Reductive Cross-Coupling of Alkyl Bromides with BCP-Thianthrenium Reagents

Affiliations

Copper-Photoredox-Catalyzed C(sp3)-C(sp3) Reductive Cross-Coupling of Alkyl Bromides with BCP-Thianthrenium Reagents

Saikat Pandit et al. Angew Chem Int Ed Engl. .

Abstract

Herein, we report a reductive cross-coupling reaction of bicyclo[1.1.1]pentyl (BCP)-thianthrenium reagents and alkyl bromides. The reaction is catalyzed by a copper/photoredox catalyst system. The approach is the first example of a cross-coupling between BCP-based reagents with alkyl electrophiles.

Keywords: Bicyclopentylation; Bioisosteres; Copper catalysis; Reductive coupling; Thianthrenium salt.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Reductive coupling of alkyl bromides with BCP‐thianthrenium salts. X, halides; PC, photocatalyst.
Figure 2
Figure 2
Proposed mechanism.
Scheme 1
Scheme 1
Substrate scope of the reductive cross‐coupling between alkyl bromides and BCP‐thianthrenium salts. General reaction conditions: alkyl bromide (0.25 mmol, 1.0 equiv.), 1b1d (2.0 equiv.), 4CzIPN (5.0 mol%), CuCl (20 mol%), TMS3SiOH (2.0 equiv.), K2HPO4 (4.0 equiv.), DMA (= 0.1 M), blue LED (460 nm, 40 W), 12 hr, 30 °C. a )CuCl2 (20 mol%) was used as catalyst, Na2CO3 (4.0 equiv.) was used as base, and DMSO (= 0.05 M) was used as solvent. d.r., diastereomeric ratio.
Scheme 2
Scheme 2
Synthesis of BCP analog of tesmilifene.

Similar articles

References

    1. Stepan A. F., Subramanyam C., Efremov I. V., Dutra J. K., O'Sullivan T. J., DiRico K. J., McDonald W. S., Won A., Dorff P. H., Nolan C. E., Becker S. L., Pustilnik L. R., Riddell D. R., Kauffman G. W., Kormos B. L., Zhang L., Lu Y., Capetta S. H., Green M. E., Karki K., Sibley E., Atchison K. P., Hallgren A. J., Oborski C. E., Robshaw A. E., Sneed B., O'Donnell C. J., J. Med. Chem. 2012, 55, 3414–3424. - PubMed
    1. Auberson Y. P., Brocklehurst C., Furegati M., Fessard T. C., Koch G., Decker A., La Vecchia L., Briard E., ChemMedChem 2017, 12, 590–598. - PubMed
    1. Goh Y. L., Cui Y. T., Pendharkar V., Adsool V. A., ACS Med. Chem. Lett. 2017, 8, 516–520. - PMC - PubMed
    1. Measom N. D., Down K. D., Hirst D. J., Jamieson C., Manas E. S., Patel V. K., Somers D. O., ACS Med. Chem. Lett. 2017, 8, 43–48. - PMC - PubMed
    1. Nilova A., Campeau L.‐C., Sherer E. C., Stuart D. R., J. Med. Chem. 2020, 63, 13389–13396. - PubMed

LinkOut - more resources